Literature DB >> 3289487

Recent advances in blood-brain barrier transport.

W M Pardridge1.   

Abstract

In summary, recent studies over the last ten years have concentrated on what the blood-brain barrier does rather than what it is. This focus has changed the concept of this important membrane from a passive, relatively immutable structure to a dynamic interface between blood and brain. Further understanding of the molecular cell physiology of the brain capillary endothelium will undoubtedly lead to new insights into both drug action at the BBB and drug delivery through this barrier.

Mesh:

Year:  1988        PMID: 3289487     DOI: 10.1146/annurev.pa.28.040188.000325

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  46 in total

Review 1.  Neural induction of the blood-brain barrier: still an enigma.

Authors:  H C Bauer; H Bauer
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

2.  Distribution of small magnetic particles in brain tumor-bearing rats.

Authors:  S K Pulfer; S L Ciccotto; J M Gallo
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 3.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.

Authors:  L M Dallasta; L A Pisarov; J E Esplen; J V Werley; A V Moses; J A Nelson; C L Achim
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

5.  Retrograde axonal transport of an exogenous enzyme covalently linked to B-IIb fragment of tetanus toxin.

Authors:  P Beaude; A Delacour; B Bizzini; D Domuado; M H Remy
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

6.  Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Authors:  Carola Förster; Malgorzata Burek; Ignacio A Romero; Babette Weksler; Pierre-Olivier Couraud; Detlev Drenckhahn
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

Review 7.  Delivering peptides to the central nervous system: dilemmas and strategies.

Authors:  W A Banks; A J Kastin; C M Barrera
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

8.  In vitro P-glycoprotein activity does not completely explain in vivo efficacy of novel centrally effective oxime acetylcholinesterase reactivators.

Authors:  Mary Beth Dail; Edward Caldwell Meek; Howard Wayne Chambers; Janice Elaine Chambers
Journal:  Drug Chem Toxicol       Date:  2018-05-03       Impact factor: 3.356

9.  Effect of feeding and fasting on plasma tryptophan and tryptophan to large neutral amino acid ratio, and on brain serotonin turnover in rainbow trout,Oncorhynchus mykiss.

Authors:  W L Johnston; N T Glanville
Journal:  Fish Physiol Biochem       Date:  1992-05       Impact factor: 2.794

10.  Assessment of valproic acid serum-cerebrospinal fluid transport by microdialysis.

Authors:  P L Golden; K R Brouwer; G M Pollack
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.